Clinical Trials Directory

Trials / Conditions / Primary Generalized Tonic-clonic Seizures

Primary Generalized Tonic-clonic Seizures

6 registered clinical trials studyying Primary Generalized Tonic-clonic Seizures — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Gen
NCT06657378
Eisai Co., Ltd.—
RecruitingA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
NCT05667142
Xenon Pharmaceuticals Inc.Phase 3
CompletedStudy to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects
NCT03288129
Eisai Inc.Phase 4
CompletedInvestigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epileps
NCT03059329
Eisai Co., Ltd.—
CompletedInvestigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence E
NCT03059381
Eisai Co., Ltd.—
CompletedStudy to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
NCT02736162
Eisai Inc.—